HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc Teitelbaum Selected Research

Ebola Hemorrhagic Fever

12/2019A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc Teitelbaum Research Topics

Disease

5COVID-19
01/2022 - 04/2021
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2023
1Ebola Hemorrhagic Fever
12/2019

Drug/Important Bio-Agent (IBA)

3remdesivirIBA
01/2022 - 11/2021
2bamlanivimabIBA
01/2022 - 11/2021
2VaccinesIBA
01/2022 - 04/2021
2Monoclonal AntibodiesIBA
01/2022 - 11/2021
2Antiviral Agents (Antivirals)IBA
01/2022 - 04/2021
1Biomarkers (Surrogate Marker)IBA
01/2023
1Staphylococcal Protein A (Protein A)IBA
01/2022
1AntigensIBA
01/2022
1ensovibepIBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022

Therapy/Procedure

3Therapeutics
01/2022 - 12/2019